Bluejay Diagnostics, Inc. (BJDX)
1.899
-0.06
(-3.11%)
USD |
NASDAQ |
Apr 24, 16:00
1.92
+0.02
(+1.12%)
After-Hours: 20:00
Bluejay Diagnostics Total Liabilities (Quarterly) : 1.144M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 55.82M |
| Plus Therapeutics, Inc. | 12.33M |
| Atossa Therapeutics, Inc. | 8.255M |
| Abeona Therapeutics, Inc. | 61.96M |
| Cell Source, Inc. | 18.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.119M |
| Shareholders Equity (Quarterly) | 5.975M |
| Debt to Equity Ratio | 0.0217 |
| Current Ratio | 4.882 |
| Net Debt Paydown Yield | 1.57% |